scispace - formally typeset
R

Robert Gallop

Researcher at West Chester University of Pennsylvania

Publications -  266
Citations -  20875

Robert Gallop is an academic researcher from West Chester University of Pennsylvania. The author has contributed to research in topics: Randomized controlled trial & Cognitive therapy. The author has an hindex of 66, co-authored 244 publications receiving 18743 citations. Previous affiliations of Robert Gallop include University of Ottawa & University of Pennsylvania.

Papers
More filters
Journal ArticleDOI

Staying well during pregnancy and the postpartum: A pilot randomized trial of mindfulness-based cognitive therapy for the prevention of depressive relapse/recurrence.

TL;DR: MBCT-PD is an acceptable and clinically beneficial program for pregnant women with histories of depression; teaching the skills and practices of mindfulness meditation and cognitive-behavioral therapy during pregnancy may help to reduce the risk of depression during an important transition in many women's lives.
Journal ArticleDOI

Dialectical Behavior Therapy (DBT) Applied to College Students: A Randomized Clinical Trial.

TL;DR: Mixed effects analyses revealed that DBT showed significantly greater decreases in suicidality, depression, number of NSSI events, BPD criteria, and psychotropic medication use and significantly greater improvements in social adjustment.
Journal ArticleDOI

The psychometric properties of the MASC in a pediatric psychiatric sample.

TL;DR: The psychometric properties of the Multidimensional Anxiety Scale for Children were examined in a clinical sample of 193 children and adolescents who had received a diagnosis of major depressive or anxiety disorder, and its subscales and items differentiated between anxious and depressed pediatric patients.
Journal ArticleDOI

Antidepressant medications v. cognitive therapy in people with depression with or without personality disorder.

TL;DR: Comorbid personality disorder was associated with differential initial response rates and sustained response rates for two well-validated treatments for depression.
Journal ArticleDOI

The Women's Recovery Group Study: a Stage I trial of women-focused group therapy for substance use disorders versus mixed-gender group drug counseling.

TL;DR: The newly developed 12-session women-focused WRG was feasible with high satisfaction among participants and demonstrated significantly greater improvement in reductions in drug and alcohol use over the post-treatment follow-up phase compared with GDC.